Renata Castelo

NPI: 1831750249
Total Payments
$1,807
2024 Payments
$833.17
Companies
24
Transactions
51
Medicare Patients
76
Medicare Billing
$6,158

Payment Breakdown by Category

Food & Beverage$1,807 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,807 51 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $246.90 7 $0 (2024)
GlaxoSmithKline, LLC. $241.04 5 $0 (2024)
E.R. Squibb & Sons, L.L.C. $126.11 1 $0 (2023)
ImmunoGen, Inc. $124.04 1 $0 (2023)
Organogenesis Inc. $120.03 1 $0 (2022)
Novartis Pharmaceuticals Corporation $114.76 4 $0 (2024)
Daiichi Sankyo Inc. $106.35 6 $0 (2024)
Tempus AI, Inc $95.40 1 $0 (2024)
Janssen Biotech, Inc. $91.63 5 $0 (2024)
Integra LifeSciences Corporation $67.18 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $833.17 29 AstraZeneca Pharmaceuticals LP ($204.38)
2023 $750.90 15 GlaxoSmithKline, LLC. ($187.58)
2022 $177.20 4 Organogenesis Inc. ($120.03)
2021 $46.00 3 Daiichi Sankyo Inc. ($46.00)

All Payment Transactions

51 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/09/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $17.92 General
Category: ONCOLOGY
11/19/2024 Novartis Pharmaceuticals Corporation LUTATHERA (Drug) Food and Beverage In-kind items and services $29.40 General
Category: Oncology
11/15/2024 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $30.90 General
Category: CELLT
10/24/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $33.34 General
10/22/2024 Tempus AI, Inc Food and Beverage In-kind items and services $95.40 General
10/03/2024 Novartis Pharmaceuticals Corporation LUTATHERA (Drug) Food and Beverage In-kind items and services $29.67 General
Category: Oncology
09/26/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $19.47 General
Category: ONCOLOGY
09/11/2024 Janssen Biotech, Inc. DARZALEX (Biological) Food and Beverage In-kind items and services $22.83 General
Category: Oncology
09/05/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $22.53 General
08/27/2024 Takeda Pharmaceuticals U.S.A., Inc. ALUNBRIG (Drug) Food and Beverage In-kind items and services $27.95 General
Category: ONCOLOGY
08/22/2024 Genmab U.S., Inc. Tivdak (Drug) Food and Beverage In-kind items and services $29.59 General
Category: Oncology
08/15/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $23.59 General
Category: ONCOLOGY
08/06/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $15.64 General
Category: ONCOLOGY
07/16/2024 Novartis Pharmaceuticals Corporation LUTATHERA (Drug) Food and Beverage In-kind items and services $31.91 General
Category: Oncology
07/16/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $23.78 General
Category: Oncology
07/09/2024 SERVIER PHARMACEUTICALS LLC Tibsovo (Drug) Food and Beverage In-kind items and services $15.05 General
Category: Oncology
07/04/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $16.07 General
Category: ONCOLOGY
07/02/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $24.44 General
Category: RADIOPHARMACEUTICAL
06/24/2024 Genmab U.S., Inc. Tivdak (Drug) Food and Beverage In-kind items and services $23.12 General
Category: Oncology
06/11/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $135.00 General
Category: Oncology
06/05/2024 Lilly USA, LLC VERZENIO (Drug) Food and Beverage In-kind items and services $26.27 General
Category: Oncology
05/22/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $14.29 General
Category: Oncology
05/07/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $26.31 General
Category: Oncology
05/06/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $1.53 General
Category: Oncology
04/30/2024 ABBVIE INC. ELAHERE (Drug) Food and Beverage In-kind items and services $20.51 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 13 13 $22,750 $1,253
2022 2 30 31 $27,700 $2,668
2021 1 21 21 $5,775 $1,500
2020 1 12 12 $3,300 $737.76
Total Patients
76
Total Services
77
Medicare Billing
$6,158
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less Facility 2023 13 13 $22,750 $1,253 5.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 18 $4,950 $1,472 29.7%
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less Facility 2022 13 13 $22,750 $1,195 5.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 21 21 $5,775 $1,500 26.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 12 12 $3,300 $737.76 22.4%

About Renata Castelo

Renata Castelo is a Surgical healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2019. The National Provider Identifier (NPI) number assigned to this provider is 1831750249.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Renata Castelo has received a total of $1,807 in payments from pharmaceutical and medical device companies, with $833.17 received in 2024. These payments were reported across 51 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,807).

As a Medicare-enrolled provider, Castelo has provided services to 76 Medicare beneficiaries, totaling 77 services with total Medicare billing of $6,158. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Surgical
  • Location Fort Worth, TX
  • Active Since 06/26/2019
  • Last Updated 02/06/2025
  • Taxonomy Code 363AS0400X
  • Entity Type Individual
  • NPI Number 1831750249

Products in Payments

  • ENHERTU (Biological) $135.00
  • REBLOZYL (Biological) $126.11
  • Elahere (Biological) $124.04
  • Puraply (Medical Supply) $120.03
  • JEMPERLI (Biological) $113.83
  • LUTATHERA (Drug) $90.98
  • LYNPARZA (Drug) $67.26
  • CODMAN CERTAS (Device) $67.18
  • TIVDAK (Biological) $65.00
  • Enhertu (Drug) $56.71
  • ERLEADA (Drug) $54.51
  • OJJAARA (Drug) $53.46
  • Tivdak (Drug) $52.71
  • Lenvima (Drug) $47.64
  • INJECTAFER (Drug) $32.79
  • Yescarta (Drug) $30.90
  • Flexitouch Plus (Device) $28.65
  • ALUNBRIG (Drug) $27.95
  • VERZENIO (Drug) $26.27
  • PYLARIFY (Drug) $24.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Surgical Doctors in Fort Worth